Thyroid involvement in hepatitis C virus-infected patients with/without mixed cryoglobulinemia

Frontiers in Endocrinology

Volumn 8, Issue JUL, 2017, Pages

  Ferri, Clodoveo ^a   Colaci, Michele ^a   Fallahi, Poupak ^b   Ferrari, Silvia Martina ^b   Antonelli, Alessandro ^b   Giuggioli, Dilia ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Autoimmune thyroiditis; Autoimmunity; Cancer; Cryoglobulinemia; Cryoglobulinemic vasculitis; Hepatitis C virus; Lymphoma; Thyroid

Indexed keywords

AUTOIMMUNITY; CONTROLLED STUDY; CRYOGLOBULINEMIA; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPOTHYROIDISM; IMMUNE RESPONSE; LYMPHOPROLIFERATIVE DISEASE; PREVALENCE; SHORT SURVEY; THYROID CANCER; THYROID DISEASE; THYROID FUNCTION; VASCULITIS;

EID: 85025465557     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2017.00159     Document Type: Short Survey

References (30)

1. Yoo WS, Chung HK. Recent advances in autoimmune thyroid diseases. Endocrinol Metab (2016) 31:379-85. doi:10.3803/EnM.2016.31.3.379
2. Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev (2015) 14:174-80. doi:10.1016/j.autrev.2014.10.016
3. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev (2014) 13:391-7. doi:10.1016/j.autrev.2014.01.007
4. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis (2008) 3:25. doi:10.1186/1750-1172-3-25
5. Ferri C, Sebastiani M, Giuggioli D, Colaci M, Fallahi P, Piluso A, et al. Hepatitis C virus syndrome: a constellation of organ-and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer. World J Hepatol (2015) 7:327-43. doi:10.4254/wjh.v7.i3.327
6. Zignego AL, Gragnani L, Piluso A, Sebastiani M, Giuggioli D, Fallahi P, et al. Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. Expert Rev Clin Immunol (2015) 11:15-31. doi:10.1586/1744666X.2015.997214
7. Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, et al. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis (2007) 39(Suppl 1):S13-21. doi:10.1016/S1590-8658(07)80005-3
8. Ferri C, Ramos-Casals M, Zignego AL, Arcaini L, Roccatello D, Antonelli A, et al. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmun Rev (2016) 15:1145-60. doi:10.1016/j.autrev.2016.09.006
9. Fallahi P, Ferrari SM, Giuggioli D, Corrado A, Fabiani S, Marchi S, et al. Mixed cryoglobulinemia and thyroid autoimmune disorders. Clin Ter (2013) 164:e337-41. doi:10.7417/CT.2013.1598
10. Fallahi P, Ferrari SM, Politti U, Giuggioli D, Ferri C, Antonelli A. Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection. Int J Endocrinol (2014) 2014:935131. doi:10.1155/2014/935131
11. Ferrari SM, Fallahi P, Mancusi C, Colaci M, Manfredi A, Ferri C, et al. HCV-related autoimmune disorders in HCV chronic infection. Clin Ter (2013) 164(4):e305-12. doi:10.7417/CT.2013.1594
12. Fallahi P, Ferrari SM, Giuggioli D, Manfredi A, Mancusi C, Fabiani S, et al. Thyroid involvement in hepatitis C-associated mixed cryoglobulinemia. Hormones (2014) 13:16-23.
13. Antonelli A, Ferri C, Ferrari SM, Colaci M, Sansonno D, Fallahi P. Endocrine manifestations of hepatitis C virus infection. Nat Clin Pract Endocrinol Metab (2009) 5:26-34. doi:10.1038/ncpendmet1027
14. Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M, et al. Thyroid disorders in chronic hepatitis C. Am J Med (2004) 117:10-3. doi:10.1016/j.amjmed.2004.01.023
15. Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA (2007) 297:2010-7. doi:10.1001/jama.297.18.2010
16. Shen Y, Wang XL, Xie JP, Shao JG, Lu YH, Zhang S, et al. Thyroid disturbance in patients with chronic hepatitis C infection: a systematic review and meta-analysis. J Gastrointestin Liver Dis (2016) 25:227-34. doi:10.15403/jgld.2014.1121.252.chc
17. Tomer Y, Blackard JT, Akeno N. Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am (2007) 36:1051-66. doi:10.1016/j.ecl.2007.07.001
18. Codes L, de Freitas LA, Santos-Jesus R, Vivitski L, Silva LK, Trepo C, et al. Comparative study of hepatitis C virus genotypes 1 and 3 in Salvador, Bahia Brazil. Braz J Infect Dis (2003) 7:409-17. doi:10.1590/S1413-86702003000600009
19. Antonelli A, Ferri C, Fallahi P, Giuggioli D, Nesti C, Longombardo G, et al. Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM (2004) 97:499-506. doi:10.1093/qjmed/hch088
20. Fallahi P, Ferrari SM, Ruffilli I, Elia G, Giuggioli D, Colaci M, et al. Incidence of thyroid disorders in mixed cryoglobulinemia: results from a longitudinal follow-up. Autoimmun Rev (2016) 15:747-51. doi:10.1016/j.autrev.2016.03.012
21. Wang P, Jing Z, Liu C, Xu M, Wang P, Wang X, et al. Hepatitis C virus infection and risk of thyroid cancer: a systematic review and meta-analysis. Arab J Gastroenterol (2017) 18:1-5. doi:10.1016/j.ajg.2017.01.003
22. Antonelli A, Ferri C, Ferrari SM, Colaci M, Fallahi P. Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. Autoimmun Rev (2008) 8:18-23. doi:10.1016/j.autrev.2008.07.017
23. Akeno N, Blackard JT, Tomer Y. HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun (2008) 31:339-44. doi:10.1016/j.jaut.2008.08.001
24. Blackard JT, Kong L, Huber AK, Tomer Y. Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of HCV and thyroiditis. Thyroid (2012) 23:863-70. doi:10.1089/thy.2012.0507
25. Antonelli A, Ferri C, Ferrari SM, De Marco S, Di Domenicantonio A, Centanni M, et al. Interleukin-1ß, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis. J Interferon Cytokine Res (2010) 30:835-42. doi:10.1089/jir.2010.0024
26. Antonelli A, Fallahi P, Ferrari SM, Colaci M, Giuggioli D, Saraceno G, et al. Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10. J Interferon Cytokine Res (2013) 33:739-45. doi:10.1089/jir.2012.0091
27. Antonelli A, Fallahi P, Ferrari SM, Sebastiani M, Manfredi A, Mazzi V, et al. Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. Mod Rheumatol (2012) 22:659-67. doi:10.1007/s10165-011-0565-x
28. Antonelli A, Ferri C, Ferrari SM, Di Domenicantonio A, Ferrari P, Pupilli C, et al. The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha. Clin Exp Rheumatol (2011) 29(1 Suppl 64):S17-22.
29. Antonelli A, Ferrari SM, Frascerra S, Pupilli C, Mancusi C, Metelli MR, et al. CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes. J Clin Endocrinol Metab (2010) 95(12):E413-20. doi:10.1210/jc.2010-0923
30. Zignego AL, Ramos-Casals M, Ferri C, Saadoun D, Arcaini L, Roccatello D, et al. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmun Rev (2017) 16:523-41. doi:10.1016/j.autrev.2017.03.004